Caitlin L. Maikawa

Caitlin L. Maikawa

Auto-generated profile, based on publicly available information

Caitlin L. Maikawa

Department of Bioengineering, Stanford University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in Science Advances
Verified
Journal Article
Open access
AGAbigail K. Grosskopf
Abigail K. Grosskopf
LLLouai Labanieh
Louai Labanieh
DKDorota D. Klysz
Dorota D. Klysz
GRGillie A. Roth
Gillie A. Roth
PXPeng Xu
Peng Xu
EAEric A. Appel
Eric A. Appel
Adoptive cell therapy (ACT) has proven to be highly effective in treating blood cancers, but traditional approaches to ACT are poorly effective in treating solid tumors observed clinically. Novel delivery methods for therapeutic cells have shown promise for treatment of solid tumors when compared with standard intravenous administration methods, but the few reported approaches leverage biomaterials that are complex to manufacture and have primarily demonstrated applicability following tumor resection or in immune-privileged tissues. Here, we engineer simple-to-implement injectable hydrogels for the controlled co-delivery of CAR-T cells and stimulatory cytokines that improve treatment of solid tumors. The unique architecture of this material simultaneously inhibits passive diffusion of entrapped cytokines and permits active motility of entrapped cells to enable long-term retention, viability, and activation of CAR-T cells. The generation of a transient inflammatory niche following administration affords sustained exposure of CAR-T cells, induces a tumor-reactive CAR-T phenotype, and improves efficacy of treatment.

1 October 2015 in Science of The Total Environment
Verified
Journal Article
Closed access
PPPallavi Pant
Pallavi Pant
SBStephen J. Baker
Stephen J. Baker
ASAnuradha Shukla
Anuradha Shukla
CMCaitlin Maikawa
Caitlin Maikawa
Krystal PollittKrystal Pollitt
Krystal Pollitt
Roy HarrisonRoy Harrison
Roy Harrison

21 December 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
MPMahla Poudineh
Mahla Poudineh
CMCaitlin L. Maikawa
Caitlin L. Maikawa
EMEric Yue Ma
Eric Yue Ma
JPJing Pan
Jing Pan
DMDan Mamerow
Dan Mamerow
HSH. Tom Soh
H. Tom Soh

1 October 2016 in Environmental Health Perspectives
Verified
Journal Article
Open access
CMCaitlin L. Maikawa
Caitlin L. Maikawa
SWScott Weichenthal
Scott Weichenthal
AWAmanda Wheeler
Amanda Wheeler
NDNina A. Dobbin
Nina A. Dobbin
ASAudrey Smargiassi
Audrey Smargiassi
Krystal PollittKrystal Pollitt
Krystal Pollitt
Background: Epidemiological studies have provided strong evidence that fine particulate matter (PM2.5; aerodynamic diameter ≤ 2.5 μm) can exacerbate asthmatic symptoms in children. Pro-oxidant components of PM2.5 are capable of directly generating reactive oxygen species. Oxidative burden is used to describe the capacity of PM2.5 to generate reactive oxygen species in the lung. Objective: In this study we investigated the association between airway inflammation in asthmatic children and oxidative burden of PM2.5 personal exposure. Methods: Daily PM2.5 personal exposure samples (n = 249) of 62 asthmatic school-aged children in Montreal were collected over 10 consecutive days. The oxidative burden of PM2.5 samples was determined in vitro as the depletion of low-molecular-weight antioxidants (ascorbate and glutathione) from a synthetic model of the fluid lining the respiratory tract. Airway inflammation was measured daily as fractional exhaled nitric oxide (FeNO). Results: A positive association was identified between FeNO and glutathione-related oxidative burden exposure in the previous 24 hr (6.0% increase per interquartile range change in glutathione). Glutathione-related oxidative burden was further found to be positively associated with FeNO over 1-day lag and 2-day lag periods. Results further demonstrate that corticosteroid use may reduce the FeNO response to elevated glutathione-related oxidative burden exposure (no use, 15.8%; irregular use, 3.8%), whereas mold (22.1%), dust (10.6%), or fur (13.1%) allergies may increase FeNO in children with versus children without these allergies (11.5%). No association was found between PM2.5 mass or ascorbate-related oxidative burden and FeNO levels. Conclusions: Exposure to PM2.5 with elevated glutathione-related oxidative burden was associated with increased FeNO. Citation: Maikawa CL, Weichenthal S, Wheeler AJ, Dobbin NA, Smargiassi A, Evans G, Liu L, Goldberg MS, Godri Pollitt KJ. 2016. Particulate oxidative burden as a predictor of exhaled nitric oxide in children with asthma. Environ Health Perspect 124:1616–1622; http://dx.doi.org/10.1289/EHP175

1 July 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JMJoseph L. Mann
Joseph L. Mann
CMCaitlin L. Maikawa
Caitlin L. Maikawa
ASAnton A. A. Smith
Anton A. A. Smith
AGAbigail K. Grosskopf
Abigail K. Grosskopf
SBSam W. Baker
Sam W. Baker
EAEric A. Appel
Eric A. Appel
Monomeric insulin stabilized with polymeric excipient exhibits increased stability and faster pharmacokinetics than current rapid-acting insulins.

11 May 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
CMCaitlin L. Maikawa
Caitlin L. Maikawa
ASAnton A. A. Smith
Anton A. A. Smith
LZLei Zou
Lei Zou
GRGillie A. Roth
Gillie A. Roth
EGEmily C. Gale
Emily C. Gale
EAEric A. Appel
Eric A. Appel